Thermo Fisher Scientific (TMO) Revenue — Quarter Ended Mar 28, 2026
Revenue declined in the current quarter compared to the prior quarter. Compared to the same quarter a year earlier, revenue increased.
Key takeaway
Quarter ended Mar 28, 2026 · FY2026 Q1
Revenue declined in the current quarter compared to the prior quarter. Compared to the same quarter a year earlier, revenue increased.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$11B
Revenue reported for this quarter.
Quarter-over-quarter
-9.9%
Change from the immediately preceding quarter.
Year-over-year
+6.2%
Change from the comparable year-ago quarter.
Trailing four quarters
$45.2B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Jun 28, 2025 | $10.9B | +3.0% |
| Sep 27, 2025 | $11.1B | +4.9% |
| Dec 31, 2025 | $12.2B | +7.2% |
| Mar 28, 2026 | $11B | +6.2% |
Revenue performance
The reported revenue moved downward from the immediately preceding quarter. The sequential decline followed a period of growth in earlier quarters.
Quarterly comparison
Revenue was higher than the same quarter one year earlier, marking a year-over-year increase. The prior year's same quarter had a lower revenue base.
What to watch
The sequential revenue decline warrants attention given the prior trend of consecutive increases.